165 related articles for article (PubMed ID: 35333880)
1. Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.
Tan B; Opoku N; Attah SK; Awadzi K; Kuesel AC; Lazdins-Helds J; Rayner C; Ryg-Cornejo V; Sullivan M; Fleckenstein L
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010005. PubMed ID: 35333880
[TBL] [Abstract][Full Text] [Related]
2. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.
Awadzi K; Opoku NO; Attah SK; Lazdins-Helds J; Kuesel AC
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2953. PubMed ID: 24968000
[TBL] [Abstract][Full Text] [Related]
3. Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia.
Kanza EM; Nyathirombo A; Larbelee JP; Opoku NO; Bakajika DK; Howard HM; Mambandu GL; Nigo MM; Wonyarossi DU; Ngave F; Kennedy KK; Kataliko K; Bolay KM; Attah SK; Olipoh G; Asare S; Mumbere M; Vaillant M; Halleux CM; Kuesel AC
Parasit Vectors; 2024 Mar; 17(1):137. PubMed ID: 38491528
[TBL] [Abstract][Full Text] [Related]
4. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
5. Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo.
Tagboto SK; Townson S
Ann Trop Med Parasitol; 1996 Oct; 90(5):497-505. PubMed ID: 8915126
[TBL] [Abstract][Full Text] [Related]
6. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
7. The blackfly vectors and transmission of Onchocerca volvulus in Mahenge, south eastern Tanzania.
Hendy A; Krüger A; Pfarr K; De Witte J; Kibweja A; Mwingira U; Dujardin JC; Post R; Colebunders R; O'Neill S; Kalinga A
Acta Trop; 2018 May; 181():50-59. PubMed ID: 29410302
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
[TBL] [Abstract][Full Text] [Related]
9. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
10. Moxidectin: an oral treatment for human onchocerciasis.
Milton P; Hamley JID; Walker M; Basáñez MG
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1067-1081. PubMed ID: 32715787
[TBL] [Abstract][Full Text] [Related]
11. The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
Abong RA; Amambo GN; Hamid AA; Enow BA; Beng AA; Nietcho FN; Nji TM; Njouendou AJ; Ritter M; Esum ME; Deribe K; Cho JF; Fombad FF; Enyong PI; Poole C; Pfarr K; Hoerauf A; Carlow C; Wanji S
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008926. PubMed ID: 33465080
[TBL] [Abstract][Full Text] [Related]
12. Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum.
Hendy A; Krit M; Pfarr K; Laemmer C; De Witte J; Nwane P; Kamgno J; Nana-Djeunga HC; Boussinesq M; Dujardin JC; Post R; Colebunders R; O'Neill S; Enyong P; Njamnshi AK
Parasit Vectors; 2021 Nov; 14(1):563. PubMed ID: 34727965
[TBL] [Abstract][Full Text] [Related]
13. Status of Onchocerca volvulus infection and transmission by blackflies after 15 years of ivermectin distribution at Adani, Nigeria.
Onah IE; Ubachukwu PO; Eyo JE
Trop Biomed; 2020 Mar; 37(1):174-185. PubMed ID: 33612728
[TBL] [Abstract][Full Text] [Related]
14. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
[TBL] [Abstract][Full Text] [Related]
15. The effect of multiple ivermectin treatments on infection of Simulium ochraceum with Onchocerca volvulus.
Cupp EW; Ochoa AO; Collins RC; Ramberg FR; Zea G
Am J Trop Med Hyg; 1989 May; 40(5):501-6. PubMed ID: 2729507
[TBL] [Abstract][Full Text] [Related]
16. Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection.
Bakajika D; Kanza EM; Opoku NO; Howard HM; Mambandu GL; Nyathirombo A; Nigo MM; Kennedy KK; Masembe SL; Mumbere M; Kataliko K; Bolay KM; Attah SK; Olipoh G; Asare S; Vaillant M; Halleux CM; Kuesel AC
PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010079. PubMed ID: 35476631
[TBL] [Abstract][Full Text] [Related]
17. Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala.
Gonzalez RJ; Cruz-Ortiz N; Rizzo N; Richards J; Zea-Flores G; Domínguez A; Sauerbrey M; Catú E; Oliva O; Richards FO; Lindblade KA
PLoS Negl Trop Dis; 2009; 3(3):e404. PubMed ID: 19333366
[TBL] [Abstract][Full Text] [Related]
18. Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With
Zhan B; Bottazzi ME; Hotez PJ; Lustigman S
Front Cell Infect Microbiol; 2022; 12():869039. PubMed ID: 35444961
[TBL] [Abstract][Full Text] [Related]
19. Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors.
Lamberton PH; Cheke RA; Winskill P; Tirados I; Walker M; Osei-Atweneboana MY; Biritwum NK; Tetteh-Kumah A; Boakye DA; Wilson MD; Post RJ; Basañez MG
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003688. PubMed ID: 25897492
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
